2022

Feldman SF, Temkin E, Wullfhart L, Nutman A, Schechner V, Shitrit P, Shvartz R, Schwaber MJ, Andremont A, Carmeli Y
A nationwide population-based study of Escherichia coli bloodstream infections: incidence, antimicrobial resistance and mortality.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2022, 28, 879.e1-879.e7.

Vehreschild MJGT, Ducher A, Louie T, Cornely OA, Feger C, Dane A, Varastet M, Vitry F, de Gunzburg J, Andremont A, Mentré F, Wilcox MH
An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones.
The Journal of Antimicrobial Chemotherapy 2022, 77, 1155-1165.

Rondinaud E, Clermont O, Petitjean M, Ruppe E, Esposito-Farèse M, Nazimoudine A, VRsg, Coignard B, Matheron S, Andremont A, Denamur E, Armand-Lefevre L
Acquisition of Enterobacterales carrying the colistin resistance gene mcr following travel to the tropics.
Journal of Travel Medicine 2022, taac141.

Levi G, Lurie-Weinberger M, Keren-Paz A, Andremont AO, Schwartz D, Carmeli Y
Unraveling the Diversity of Co-Colonization by CPE.
Microorganisms 2022, 10, 1292.

2021

Guk J, Guedj J, Burdet C, Andremont A, de Gunzburg J, Ducher A, Mentré F
Modeling the Effect of DAV132, a Novel Colon-Targeted Adsorbent, on Fecal Concentrations of Moxifloxacin and Gut Microbiota Diversity in Healthy Volunteers.
Clinical Pharmacology and Therapeutics 2021, 109, 1045-1054.

Ronat JB, Natale A, Kesteman T, Andremont A, Elamin W, Hardy L, Kanapathipillai R, Michel J, Langendorf C, Vandenberg O, Naas T, Kouassi F
AMR in low-resource settings: Médecins Sans Frontières bridges surveillance gaps by developing a turnkey solution, the Mini-Lab.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2021, 27, 1414-1421.

Andremont A, Cervesi J, Bandinelli PA, Vitry F, de Gunzburg J
Spare and repair the gut microbiota from antibiotic-induced dysbiosis: state-of-the-art.
Drug Discovery Today 2021, 26, 2159-2163.

Armand-Lefèvre L, Rondinaud E, Desvillechabrol D, Mullaert J, Clermont O, Petitjean M, Ruppe E, Cokelaer T, Bouchier C, Tenaillon O, Ma L, Nooroya Y, Matheron S, The Voyag-R Study Group n, Andremont A, Denamur E, Kennedy SP
Dynamics of extended-spectrum beta-lactamase-producing Enterobacterales colonization in long-term carriers following travel abroad.
Microbial Genomics 2021, 7, 000576.

Milenkov M, Rasoanandrasana S, Rahajamanana LV, Rakotomalala RS, Razafindrakoto CA, Rafalimanana C, Ravelomandranto E, Ravaoarisaina Z, Westeel E, Petitjean M, Mullaert J, Clermont O, Raskine L, Samison LH, Endtz H, Andremont A, Denamur E, Komurian-Pradel F, Armand-Lefevre L
Prevalence, Risk Factors, and Genetic Characterization of Extended-Spectrum Beta-Lactamase Escherichia coli Isolated From Healthy Pregnant Women in Madagascar.
Frontiers in Microbiology 2021, 12, 786146.

2020

Andremont O, Armand-Lefevre L, Dupuis C, de Montmollin E, Ruckly S, Lucet JC, Smonig R, Magalhaes E, Ruppé E, Mourvillier B, Lebut J, Lermuzeaux M, Sonneville R, Bouadma L, Timsit JF, Cnc
Semi-quantitative cultures of throat and rectal swabs are efficient tests to predict ESBL-Enterobacterales ventilator-associated pneumonia in mechanically ventilated ESBL carriers.
Intensive Care Medicine 2020, 46, 1232-1242.

Lurienne L, Cervesi J, Duhalde L, de Gunzburg J, Andremont A, Zalcman G, Buffet R, Bandinelli PA
NSCLC Immunotherapy Efficacy and Antibiotic Use: A Systematic Review and Meta-Analysis.
Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 2020, 15, 1147-1159.

Jouvin-Marche E, Carrara G, Pulcini C, Andremont A, Danan C, Couderc-Obert C, Lienhardt C, Kieny MP, Yazdanpanah Y
French research strategy to tackle antimicrobial resistance.
The Lancet 2020, 395, 1239-1241.

Chilton CH, Crowther GS, Miossec C, de Gunzburg J, Andremont A, Wilcox MH
Investigation of the effect of the adsorbent DAV131A on the propensity of moxifloxacin to induce simulated Clostridioides (Clostridium) difficile infection (CDI) in an in vitro human gut model.
The Journal of Antimicrobial Chemotherapy 2020, 75, 1458-1465.

Maataoui N, Langendorf C, Berthe F, Bayjanov JR, van Schaik W, Isanaka S, Grais RF, Clermont O, Andremont A, Armand-Lefèvre L, Woerther PL
Increased risk of acquisition and transmission of ESBL-producing Enterobacteriaceae in malnourished children exposed to amoxicillin.
The Journal of Antimicrobial Chemotherapy 2020, 75, 709-717.

Harris HC, Best EL, Normington C, Saint-Lu N, Sablier-Gallis F, de Gunzburg J, Andremont A, Wilcox MH, Chilton CH
Optimization of an Assay To Determine Colonization Resistance to Clostridioides difficile in Fecal Samples from Healthy Subjects and Those Treated with Antibiotics.
Antimicrobial Agents and Chemotherapy 2020, 65,

Bailly S, Gautier-Veyret E, Lê MP, Bouadma L, Andremont O, Neuville M, Mourvillier B, Sonneville R, Magalhaes E, Lebut J, Radjou A, Smonig R, Wolff M, Massias L, Dupuis C, Timsit JF
Impact of Loading Dose of Caspofungin in Pharmacokinetic-Pharmacodynamic Target Attainment for Severe Candidiasis Infections in Patients in Intensive Care Units: the CASPOLOAD Study.
Antimicrobial Agents and Chemotherapy 2020, 64, e01545-20.

Goulas A, Belhadi D, Descamps A, Andremont A, Benoit P, Courtois S, Dagot C, Grall N, Makowski D, Nazaret S, Nelieu S, Patureau D, Petit F, Roose-Amsaleg C, Vittecoq M, Livoreil B, Laouenan C
How effective are strategies to control the dissemination of antibiotic resistance in the environment? A systematic review.
Environmental Evidence 2020, 9, 4.

Djuikoue IC, Tambo E, Tazemda G, Njajou O, Makoudjou D, Sokeng V, Wandji M, Tomi C, Nanfack A, Dayomo A, Lacmago S, Tassadjo F, Sipowo RT, Kakam C, Djoko AB, Assob CN, Andremont A, Barbut F
Evaluation of inpatients Clostridium difficile prevalence and risk factors in Cameroon.
Infectious Diseases of Poverty 2020, 9, 122.

Pierre-Audigier C, Talla C, Alame-Emane AK, Audigier B, Grall N, Ruimy R, Andremont A, Cadet-Daniel V, Sola C, Takiff H, Gicquel B, Vray M, Armand-Lefevre L
Tuberculosis trends in a hot-spot region in Paris, France.
The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union Against Tuberculosis and Lung Disease 2020, 24, 428-435.

2019

Maataoui N, Mayet A, Duron S, Delacour H, Mentré F, Laouenan C, Desvillechabrol D, Cokelaer T, Meynard JB, Ducher A, Andremont A, Armand-Lefèvre L, Mérens A
High acquisition rate of extended-spectrum β-lactamase-producing Enterobacteriaceae among French military personnel on mission abroad, without evidence of inter-individual transmission.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2019, 25, 631.e1-631.e9.

Ruppé E, Ghozlane A, Tap J, Pons N, Alvarez AS, Maziers N, Cuesta T, Hernando-Amado S, Clares I, Martínez JL, Coque TM, Baquero F, Lanza VF, Máiz L, Goulenok T, de Lastours V, Amor N, Fantin B, Wieder I, Andremont A, van Schaik W, Rogers M, Zhang X, Willems RJL, de Brevern AG, Batto JM, Blottière HM, Léonard P, Léjard V, Letur A, Levenez F, Weiszer K, Haimet F, Doré J, Kennedy SP, Ehrlich SD
Prediction of the intestinal resistome by a three-dimensional structure-based method.
Nature Microbiology 2019, 4, 112-123.

Leo S, Lazarevic V, Gaïa N, Estellat C, Girard M, Matheron S, Armand-Lefèvre L, Andremont A, Schrenzel J, Ruppé E
The intestinal microbiota predisposes to traveler's diarrhea and to the carriage of multidrug-resistant Enterobacteriaceae after traveling to tropical regions.
Gut Microbes 2019, 10, 631-641.

Burdet C, Nguyen TT, Duval X, Ferreira S, Andremont A, Guedj J, Mentré F, DC1SG
Impact of Antibiotic Gut Exposure on the Temporal Changes in Microbiome Diversity.
Antimicrobial Agents and Chemotherapy 2019, 63, e00820-19.

Saint-Lu N, Burdet C, Sablier-Gallis F, Corbel T, Nevière A, Sayah-Jeanne S, Pulse M, Weiss W, Ferreira S, Andremont A, Mentré F, de Gunzburg J
DAV131A Protects Hamsters from Lethal Clostridioides difficile Infection Induced by Fluoroquinolones.
Antimicrobial Agents and Chemotherapy 2019, 64, e01196-19.

Burdet C, Grall N, Linard M, Bridier-Nahmias A, Benhayoun M, Bourabha K, Magnan M, Clermont O, d'Humières C, Tenaillon O, Denamur E, Massias L, Tubiana S, Alavoine L, Andremont A, Mentré F, Duval X, CG
Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens.
Antimicrobial Agents and Chemotherapy 2019, 63, e02244-18.

Smonig R, Magalhaes E, Bouadma L, Andremont O, de Montmollin E, Essardy F, Mourvillier B, Lebut J, Dupuis C, Neuville M, Lermuzeaux M, Timsit JF, Sonneville R
Impact of natural light exposure on delirium burden in adult patients receiving invasive mechanical ventilation in the ICU: a prospective study.
Annals of Intensive Care 2019, 9, 120.

Matar GM, Andremont A, Bazzi W
Editorial: Combating Antimicrobial Resistance - A One Health Approach.
Frontiers in Cellular and Infection Microbiology 2019, 9, 458.

Dupouy V, Abdelli M, Moyano G, Arpaillange N, Bibbal D, Cadiergues MC, Lopez-Pulin D, Sayah-Jeanne S, de Gunzburg J, Saint-Lu N, Gonzalez-Zorn B, Andremont A, Bousquet-Mélou A
Prevalence of Beta-Lactam and Quinolone/Fluoroquinolone Resistance in Enterobacteriaceae From Dogs in France and Spain-Characterization of ESBL/pAmpC Isolates, Genes, and Conjugative Plasmids.
Frontiers in Veterinary Science 2019, 6, 279.

2018

Loubet P, Burdet C, Vindrios W, Grall N, Wolff M, Yazdanpanah Y, Andremont A, Duval X, Lescure FX
Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review.
Clin Microbiol Infect 2018, 24, 125-132.

Ruppe E, Burdet C, Grall N, de Lastours V, Lescure FX, Andremont A, Armand-Lefevre L
Impact of antibiotics on the intestinal microbiota needs to be re-defined to optimize antibiotic usage.
Clin Microbiol Infect 2018, 24, 3-5.

Larsson DGJ, Andremont A, Bengtsson-Palme J, Brandt KK, de Roda Husman AM, Fagerstedt P, Fick J, Flach CF, Gaze WH, Kuroda M, Kvint K, Laxminarayan R, Manaia CM, Nielsen KM, Plant L, Ploy MC, Segovia C, Simonet P, Smalla K, Snape J, Topp E, van Hengel AJ, Verner-Jeffreys DW, Virta MPJ, Wellington EM, Wernersson AS
Critical knowledge gaps and research needs related to the environmental dimensions of antibiotic resistance.
Environment International 2018, 117, 132-138.

Armand-Lefèvre L, Andremont A, Ruppé E
Travel and acquisition of multidrug-resistant Enterobacteriaceae.
Medecine Et Maladies Infectieuses 2018, 48, 431-441.

Ruppé E, Andremont A, Armand-Lefèvre L
Digestive tract colonization by multidrug-resistant Enterobacteriaceae in travellers: An update.
Travel Medicine and Infectious Disease 2018, 21, 28-35.

Andremont A
Too Early to Recommend Early Fecal Microbiota Transplantation in Patients With Severe Clostridium difficile Infection, or Not Too Early?.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 66, 651-652.

Pérez-Brocal V, Andremont A, Moya A
Isolation in small populations of Wayampi Amerindians promotes endemicity and homogenisation of their faecal virome, but its distribution is not entirely random.
FEMS microbiology ecology 2018, 94,

de Gunzburg J, Ghozlane A, Ducher A, Le Chatelier E, Duval X, Ruppe E, Armand-Lefevre L, Sablier-Gallis F, Burdet C, Alavoine L, Chachaty E, Augustin V, Varastet M, Levenez F, Kennedy S, Pons N, Mentre F, Andremont A
Protection of the Human Gut Microbiome From Antibiotics.
J Infect Dis 2018, 217, 628-636.

Burdet C, Sayah-Jeanne S, Nguyen TT, Hugon P, Sablier-Gallis F, Saint-Lu N, Corbel T, Ferreira S, Pulse M, Weiss W, Andremont A, Mentré F, de Gunzburg J
Antibiotic-Induced Dysbiosis Predicts Mortality in an Animal Model of Clostridium difficile Infection.
Antimicrobial Agents and Chemotherapy 2018, 62, e00925-18.

Goulas A, Livoreil B, Grall N, Benoit P, Couderc-Obert C, Dagot C, Patureau D, Petit F, Laouénan C, Andremont A
What are the effective solutions to control the dissemination of antibiotic resistance in the environment? A systematic review protocol.
Environmental Evidence 2018, 7, 3.

Lanza VF, Baquero F, Martínez JL, Ramos-Ruíz R, González-Zorn B, Andremont A, Sánchez-Valenzuela A, Ehrlich SD, Kennedy S, Ruppé E, van Schaik W, Willems RJ, de la Cruz F, Coque TM
In-depth resistome analysis by targeted metagenomics.
Microbiome 2018, 6, 11.

Sanneh B, Kebbeh A, Jallow HS, Camara Y, Mwamakamba LW, Ceesay IF, Barrow E, Sowe FO, Sambou SM, Baldeh I, Jallow A, Jorge Raul MA, Andremont A
Prevalence and risk factors for faecal carriage of Extended Spectrum β-lactamase producing Enterobacteriaceae among food handlers in lower basic schools in West Coast Region of The Gambia.
PloS One 2018, 13, e0200894.

Lorme F, Maataoui N, Rondinaud E, Esposito-Farèse M, Clermont O, Ruppe E, Arlet G, Genel N, VRsg, Matheron S, Andremont A, Armand-Lefevre L
Acquisition of plasmid-mediated cephalosporinase producing Enterobacteriaceae after a travel to the tropics.
PloS One 2018, 13, e0206909.

2017

Grall N, Lazarevic V, Gaia N, Couffignal C, Laouenan C, Ilic-Habensus E, Wieder I, Plesiat P, Angebault C, Bougnoux ME, Armand-Lefevre L, Andremont A, Duval X, Schrenzel J
Unexpected persistence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the faecal microbiota of hospitalised patients treated with imipenem.
Int J Antimicrob Agents 2017, 50, 81-87.

Tammaro P, Richard N, Andre B, Andremont A, Mammeri H
First report of human infection due to Streptococcus devriesei.
New Microbes and New Infections 2017, 15, 72-73.

Armand-Lefevre L, Ruppé E, Andremont A
ESBL-producing Enterobacteriaceae in travellers: doctors beware.
The Lancet. Infectious Diseases 2017, 17, 8-9.

Leblanc S, Blein C, Andremont A, Bandinelli PA, Galvain T
Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective.
Infection Control and Hospital Epidemiology 2017, 38, 906-911.

Woerther PL, Andremont A, Kantele A
Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level.
Journal of Travel Medicine 2017, 24, S29-S34.

Burdet C, Sayah-Jeanne S, Nguyen TT, Miossec C, Saint-Lu N, Pulse M, Weiss W, Andremont A, Mentré F, de Gunzburg J
Protection of Hamsters from Mortality by Reducing Fecal Moxifloxacin Concentration with DAV131A in a Model of Moxifloxacin-Induced Clostridium difficile Colitis.
Antimicrobial Agents and Chemotherapy 2017, 61, e00543-17.

Massot M, Couffignal C, Clermont O, D'Humières C, Chatel J, Plault N, Andremont A, Caron A, Mentré F, Denamur E
Day-to-Day Dynamics of Commensal Escherichia coli in Zimbabwean Cows Evidence Temporal Fluctuations within a Host-Specific Population Structure.
Applied and Environmental Microbiology 2017, 83, e00659-17.

Kardaś-Słoma L, Lucet JC, Perozziello A, Pelat C, Birgand G, Ruppé E, Boëlle PY, Andremont A, Yazdanpanah Y
Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis.
BMJ open 2017, 7, e017402.

Sangare SA, Rondinaud E, Maataoui N, Maiga AI, Guindo I, Maiga A, Camara N, Dicko OA, Dao S, Diallo S, Bougoudogo F, Andremont A, Maiga II, Armand-Lefevre L
Very high prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in bacteriemic patients hospitalized in teaching hospitals in Bamako, Mali.
PloS One 2017, 12, e0172652.

Sangaré SA, Maïga AI, Maïga A, Diallo S, Camara N, Savadogo S, Guindo I, Bougoudogo F, Armand-Lefèvre L, Andremont A, Maïga II
Prevalence of extended-spectrum beta-lactamase phenotypes in enterobacteria isolated from blood cultures of patients at admission to the University Hospital of Bamako.
Medecine Et Sante Tropicales 2017, 27, 170-175.

Wuijts S, van den Berg HHJL, Miller J, Abebe L, Sobsey M, Andremont A, Medlicott KO, van Passel MWJ, de Roda Husman AM
Towards a research agenda for water, sanitation and antimicrobial resistance.
Journal of Water and Health 2017, 15, 175-184.

2016

Bernard J, Armand-Lefèvre L, Luce E, El Mniai A, Chau F, Casalino E, Andremont A, Ruppé E
Impact of a short exposure to levofloxacin on faecal densities and relative abundance of total and quinolone-resistant Enterobacteriaceae.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2016, 22, 646.e1-4.

Poirier C, Dinh A, Salomon J, Grall N, Andremont A, Bernard L
Prevention of urinary tract infections by antibiotic cycling in spinal cord injury patients and low emergence of multidrug resistant bacteria.
Médecine Et Maladies Infectieuses 2016, 46, 294-299.

Ruppé E, Chatelier EL, Pons N, Andremont A, Ehrlich SD
Dissemination of the mcr-1 colistin resistance gene.
The Lancet. Infectious Diseases 2016, 16, 290-291.

Pelat C, Kardaś-Słoma L, Birgand G, Ruppé E, Schwarzinger M, Andremont A, Lucet JC, Yazdanpanah Y
Hand Hygiene, Cohorting, or Antibiotic Restriction to Control Outbreaks of Multidrug-Resistant Enterobacteriaceae.
Infection Control and Hospital Epidemiology 2016, 37, 272-280.

Collignon PC, Conly JM, Andremont A, McEwen SA, Aidara-Kane A, WHOAGBMoISoAR(A, Agerso Y, Andremont A, Collignon P, Conly J, Dang Ninh T, Donado-Godoy P, Fedorka-Cray P, Fernandez H, Galas M, Irwin R, Karp B, Matar G, McDermott P, McEwen S, Mitema E, Reid-Smith R, Scott HM, Singh R, DeWaal CS, Stelling J, Toleman M, Watanabe H, Woo GJ
World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal Production.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 63, 1087-1093.

Skurnik D, Clermont O, Guillard T, Launay A, Danilchanka O, Pons S, Diancourt L, Lebreton F, Kadlec K, Roux D, Jiang D, Dion S, Ashard H, Denamur M, Cywes-Bentley C, Schwarz S, Tenaillon O, Andremont A, Picard B, Mekalanos J, Brisse S, Denamur E
Emergence of Antimicrobial-Resistant Escherichia coli of Animal Origin Spreading in Humans.
Molecular Biology and Evolution 2016, 33, 898.

Mercat M, Clermont O, Massot M, Ruppe E, de Garine-Wichatitsky M, Miguel E, Valls Fox H, Cornelis D, Andremont A, Denamur E, Caron A
Escherichia coli Population Structure and Antibiotic Resistance at a Buffalo/Cattle Interface in Southern Africa.
Applied and Environmental Microbiology 2016, 82, 1459-1467.

Djuikoue IC, Woerther PL, Toukam M, Burdet C, Ruppe E, Gonsu KH, Fokunang C, El Mniai A, Larissa K, Pieme AC, Mboupaing MG, Kakam CM, Fogang HK, Andremont A, Ngogang J
Intestinal carriage of Extended Spectrum Beta-Lactamase producing E. coli in women with urinary tract infections, Cameroon.
J Infect Dev Ctries 2016, 10, 1135-1139.

Sangare SA, Maiga AI, Guindo I, Maiga A, Camara N, Dicko OA, Diallo S, Bougoudogo F, Armand-Lefevre L, Andremont A, Maiga II
Prevalence of ESBL-producing Enterobacteriaceae isolated from blood cultures in Mali.
Journal of Infection in Developing Countries 2016, 10, 1059-1064.

2015

Le Dorze M, Gault N, Foucrier A, Ruppé E, Mourvillier B, Woerther PL, Birgand G, Montravers P, Dilly MP, Tubach F, Andremont A, Timsit JF, Wolff M, Armand-Lefèvre L
Performance and impact of a rapid method combining mass spectrometry and direct antimicrobial susceptibility testing on treatment adequacy of patients with ventilator-associated pneumonia.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 468.e1-6.

Poirier C, Dinh A, Salomon J, Grall N, Andremont A, Bernard L
Antibiotic cycling prevents urinary tract infections in spinal cord injury patients and limits the emergence of multidrug resistant organism.
The Journal of Infection 2015

Sangare SA, Maiga AI, Guindo I, Maiga A, Camara N, Savadogo S, Diallo S, Bougoudogo F, Armand-Lefevre L, Andremont A, Maiga II
Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated from blood cultures in Africa.
Médecine Et Maladies Infectieuses 2015, 45, 374-382.

Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, Goujon C, Ralaimazava P, Campa P, Girard PM, Wyplosz B, Vittecoq D, Bouchaud O, Le Loup G, Pialoux G, Perrier M, Wieder I, Moussa N, Esposito-Farèse M, Hoffmann I, Coignard B, Lucet JC, Andremont A, Matheron S
High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 593-600.

Grall N, Barraud O, Wieder I, Hua A, Perrier M, Babosan A, Gaschet M, Clermont O, Denamur E, Catzeflis F, Decré D, Ploy MC, Andremont A
Lack of dissemination of acquired resistance to β-lactam in small wild mammals around an isolated village in the Amazonian forest.
Environmental Microbiology Reports 2015

Gosalbes MJ, Vázquez-Castellanos JF, Angebault C, Woerther PL, Ruppé E, Ferrús ML, Latorre A, Andremont A, Moya A
Carriage of enterobacteria producing extended spectrum beta-lactamases and composition of the gut microbiota in an Amerindian community.
Antimicrobial Agents and Chemotherapy 2015

Andremont A, Fiona Fleck n
What to do about resistant bacteria in the food-chain?.
Bulletin of the World Health Organization 2015, 93, 217-218.

2014

de Gunzburg J, Ducher A, Modess C, Wegner D, Oswald S, Dressman J, Augustin V, Feger C, Andremont A, Weitschies W, Siegmund W
Targeted adsorption of molecules in the colon with the novel adsorbent-based medicinal product, DAV132: a proof of concept study in healthy subjects.
Journal of Clinical Pharmacology 2014

Neulier C, Birgand G, Ruppé E, Armand-Lefèvre L, Lolom I, Yazdanpanah Y, Lucet JC, Andremont A
Enterobacteriaceae bacteremia: Risk factors for ESBLPE.
Médecine et maladies infectieuses 2014, 44, 32-38.

Birgand G, Schwarzinger M, Perozziello A, Lolom I, Pelat C, Armand-Lefevre L, Buzzi JC, Andremont A, Yazdanpanah Y, Lucet JC
Prolonged hospital stay, an adverse effect of strict national policy for controlling the spread of highly resistant microorganisms.
Infection Control and Hospital Epidemiology 2014, 35, 1427-1429.

Birgand G, Armand-Lefevre L, Lepainteur M, Lolom I, Neulier C, Reibel F, Yazdanpanah Y, Andremont A, Lucet JC
Introduction of highly resistant bacteria into a hospital via patients repatriated or recently hospitalized in a foreign country.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases [RESEARCH NOTE] 2014, 20, O887-890.

Bourgeois-Nicolaos N, Nguyen TT, Defrance G, Massias L, Alavoine L, Lefort A, Noel V, Senneville E, Doucet-Populaire F, Mentré F, Andremont A, Duval X
The emergence of linezolid resistance among Enterococci in intestinal microbiota of treated patients is unrelated to individual pharmacokinetic characteristics.
Antimicrobial Agents and Chemotherapy 2014, 58, 2681–2687.

Nguyen TT, Guedj J, Chachaty E, de Gunzburg J, Andremont A, Mentré F
Mathematical modeling of bacterial kinetics to predict the impact of antibiotic colonic exposure and treatment duration on the amount of resistant enterobacteria excreted.
PLoS computational biology 2014, 10, e1003840.

Soubirou JF, Gault N, Alfaiate T, Lolom I, Tubach F, Andremont A, Lucet JC, Wolff M, Barbier F
Ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacilli in an intensive care unit without carbapenemase-producing Enterobacteriaceae or epidemic Acinetobacter baumannii.
Scandinavian Journal of Infectious Diseases 2014, 46, 215-220.

Ruppe E, Armand-Lefevre L, Estellat C, El-Mniai A, Boussadia Y, Consigny P, Girard P, Vittecoq D, Bouchaud O, Pialoux G, Esposito-Farese M, Coignard B, Lucet J, Andremont A, Matheron S
Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013.
Euro surveillance: bulletin Européen sur les maladies transmissibles = European communicable disease bulletin 2014, 19,

2013

Angebault C, Andremont A
Antimicrobial agent exposure and the emergence and spread of resistant microorganisms: issues associated with study design.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2013, 32, 581-595.

Birgand G, Armand-Lefevre L, Lolom I, Ruppe E, Andremont A, Lucet JC
Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge.
American Journal of Infection Control 2013, 41, 443-447.

Aidara-Kane A, Andremont A, Collignon P
Antimicrobial resistance in the food chain and the AGISAR initiative.
Journal of Infection and Public Health 2013, 6, 162-165.

Defrance G, Birgand G, Ruppé E, Billard M, Ruimy R, Bonnal C, Andremont A, Armand-Lefèvre L
Time-to-positivity-based discrimination between Enterobacteriaceae, Pseudomonas aeruginosa and strictly anaerobic Gram-negative bacilli in aerobic and anaerobic blood culture vials.
Journal of Microbiological Methods 2013, 93, 77-79.

Andremont A, Lucet JC
Extensively resistant VIM-2-positive Pseudomonas aeruginosa.
The Lancet. Infectious Diseases 2013, 13, 828-829.

Kluytmans J, Price L, Grayson L, Gottlieb T, Mehtar S, Andremont A, Wegener HC, Johnson J
Enterobacteria: Ban resistant strains from food chain.
Nature 2013, 501, 316.

Angebault C, Djossou F, Abélanet S, Permal E, Ben Soltana M, Diancourt L, Bouchier C, Woerther PL, Catzeflis F, Andremont A, d'Enfert C, Bougnoux ME
Candida albicans is not always the preferential yeast colonizing humans: a study in Wayampi Amerindians.
The Journal of Infectious Diseases 2013, 208, 1705-1716.

Huttner B, Haustein T, Uçkay I, Renzi G, Stewardson A, Schaerrer D, Agostinho A, Andremont A, Schrenzel J, Pittet D, Harbarth S
Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2375-2382.

Gravey F, Galopin S, Grall N, Auzou M, Andremont A, Leclercq R, Cattoir V
Lincosamide resistance mediated by lnu(C) (L phenotype) in a Streptococcus anginosus clinical isolate.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2464-2467.

Barbier F, Andremont A, Wolff M, Bouadma L
Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management.
Current Opinion in Pulmonary Medicine 2013, 19, 216-228.

Lescat M, Clermont O, Woerther PL, Glodt J, Dion S, Skurnik D, Djossou F, Dupont C, Perroz G, Picard B, Catzeflis F, Andremont A, Denamur E
Commensal Escherichia coli strains in Guiana reveal a high genetic diversity with host-dependant population structure.
Environmental Microbiology Reports 2013, 5, 49-57.

Grall N, Massias L, Nguyen TT, Sayah-Jeanne S, Ducrot N, Chachaty E, de Gunzburg J, Andremont A
Oral DAV131, a charcoal-based adsorbent, inhibits intestinal colonization by β-lactam-resistant Klebsiella pneumoniae in cefotaxime-treated mice.
Antimicrobial Agents and Chemotherapy 2013, 57, 5423–5425.

Ruppé E, Lixandru B, Cojocaru R, Büke C, Paramythiotou E, Angebault C, Visseaux C, Djuikoue I, Erdem E, Burduniuc O, El Mniai A, Marcel C, Perrier M, Kesteman T, Clermont O, Denamur E, Armand-Lefèvre L, Andremont A
Relative fecal abundance of extended-spectrum-β-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women.
Antimicrobial Agents and Chemotherapy 2013, 57, 4512-4517.

Armand-Lefevre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppe E, Bronchard R, Lepeule R, Lucet JC, El Mniai A, Wolff M, Montravers P, Plesiat P, Andremont A
Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients.
Antimicrobial Agents and Chemotherapy 2013, 57, 1488-1495.

Woerther PL, Burdet C, Chachaty E, Andremont A
Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.
Clinical Microbiology Reviews 2013, 26, 744–758.

Birgand G, Ruimy R, Schwarzinger M, Lolom I, Bendjelloul G, Houhou N, Armand-Lefevre L, Andremont A, Yazdanpanah Y, Lucet JC
Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs.
Antimicrobial Resistance and Infection Control 2013, 2, 30.

Ruppé E, Andremont A
Causes, consequences, and perspectives in the variations of intestinal density of colonization of multidrug-resistant enterobacteria.
Frontiers in Microbiology 2013, 4, 129.

2012

Ruppe E, Pitsch A, Tubach F, de Lastours V, Chau F, Pasquet B, Lucet JC, Andremont A, Fantin B
Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards.
European Journal of Clinical Microbiology & Infectious Diseases 2012, 31, 319-325.

Diamantis S, Rioux C, Bonnal C, Farfour É, Papy E, Andremont A, Yeni P, Bouvet É, Lucet JC
Suitability of initial antibiotic therapy for the treatment of bloodstream infections and the potential role of antibiotic management teams in improving it.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2012, 31, 1667-1671.

Thiébaut ACM, Arlet G, Andremont A, Papy E, Sollet JP, Bernède-Bauduin C, Guillemot D, Schlemmer B, CSG
Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1525-1536.

François B, Luyt CE, Dugard A, Wolff M, Diehl JL, Jaber S, Forel JM, Garot D, Kipnis E, Mebazaa A, Misset B, Andremont A, Ploy MC, Jacobs A, Yarranton G, Pearce T, Fagon JY, Chastre J
Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: a randomized,double-blind, placebo-controlled trial.
Critical Care Medicine 2012, 40, 2320-2326.

Lebeaux D, Barbier F, Angebault C, Benmahdi L, Ruppé E, Felix B, Gaillard K, Djossou F, Epelboin L, Dupont C, Renard M, Peroz G, Vandenesch F, Wolff M, Andremont A, Ruimy R
Evolution of nasal carriage of methicillin-resistant coagulase-negative staphylococci in a remote population.
Antimicrobial Agents and Chemotherapy 2012, 56, 315-323.

Nguyen TT, Chachaty E, Huy C, Cambier C, de Gunzburg J, Mentré F, Andremont A
Correlation between fecal concentrations of ciprofloxacin and fecal counts of resistant Enterobacteriaceae in piglets treated with ciprofloxacin: toward new means to control the spread of resistance?.
Antimicrobial Agents and Chemotherapy 2012, 56, 4973–4975.

Roux D, Huy C, Lolom I, Andremont A, Arlet G, Armand-Lefevre L, Lucet JC
Diversity of extended-spectrum β-lactamase-producing Enterobacteriaceae on hospital admission.
Scandinavian Journal of Infectious Diseases 2012, 44, 231-236.

Woerther PL, Andremont A
[How to explain antibiotic resistance?].
La Revue Du Praticien 2012, 62, 967-971.

2011

Woerther PL, Angebault C, Jacquier H, Hugede HC, Janssens AC, Sayadi S, El Mniai A, Armand-Lefèvre L, Ruppé E, Barbier F, Raskine L, Page AL, de Rekeneire N, Andremont A
Massive increase, spread, and exchange of extended spectrum β-lactamase-encoding genes among intestinal Enterobacteriaceae in hospitalized children with severe acute malnutrition in Niger.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2011, 53, 677-685.

Lepelletier D, Andremont A, Grandbastien B, NWG
Risk of highly resistant bacteria importation from repatriates and travelers hospitalized in foreign countries: about the French recommendations to limit their spread.
Journal of Travel Medicine 2011, 18, 344-351.

2010

Jarlier V, Trystram D, Brun-Buisson C, Fournier S, Carbonne A, Marty L, Andremont A, Arlet G, Buu-Hoi A, Carlet J, Decré D, Gottot S, Gutmann L, Joly-Guillou ML, Legrand P, Nicolas-Chanoine MH, Soussy CJ, Wolf M, Lucet JC, Aggoune M, Brücker G, Régnier B, CdBVHdHUdldF
Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program.
Archives of Internal Medicine 2010, 170, 552-559.

Woerther PL, Angebault C, Lescat M, Ruppé E, Skurnik D, Mniai AE, Clermont O, Jacquier H, Costa AD, Renard M, Bettinger RM, Epelboin L, Dupont C, Guillemot D, Rousset F, Arlet G, Denamur E, Djossou F, Andremont A
Emergence and dissemination of extended-spectrum beta-lactamase-producing Escherichia coli in the community: lessons from the study of a remote and controlled population.
The Journal of Infectious Diseases 2010, 202, 515-523.

2009

Lucet JC, Paoletti X, Demontpion C, Degrave M, Vanjak D, Vincent C, Andremont A, Jarlier V, Mentré F, Nicolas-Chanoine MH, SaRalMeHAD(HSG
Carriage of methicillin-resistant Staphylococcus aureus in home care settings: prevalence, duration, and transmission to household members.
Archives of Internal Medicine 2009, 169, 1372-1378.

Fantin B, Duval X, Massias L, Alavoine L, Chau F, Retout S, Andremont A, Mentré F
Ciprofloxacin dosage and emergence of resistance in human commensal bacteria.
The Journal of Infectious Diseases 2009, 200, 390-398.

Skurnik D, Lacheeb S, Bernede C, le Menac'h A, Elbaz S, Mohler J, Denamur E, Andremont A, Ruimy R
Integrons and antibiotic resistance in phylogenetic group B2 Escherichia coli.
Microbial Drug Resistance (Larchmont, N.Y.) 2009, 15, 173-178.

2008

Skurnik D, Bonnet D, Bernède-Bauduin C, Michel R, Guette C, Becker JM, Balaire C, Chau F, Mohler J, Jarlier V, Boutin JP, Moreau B, Guillemot D, Denamur E, Andremont A, Ruimy R
Characteristics of human intestinal Escherichia coli with changing environments.
Environmental Microbiology 2008, 10, 2132-2137.

2006

Skurnik D, Ruimy R, Andremont A, Amorin C, Rouquet P, Picard B, Denamur E
Effect of human vicinity on antimicrobial resistance and integrons in animal faecal Escherichia coli.
The Journal of Antimicrobial Chemotherapy 2006, 57, 1215-1219.

2005

Skurnik D, Le Menac'h A, Zurakowski D, Mazel D, Courvalin P, Denamur E, Andremont A, Ruimy R
Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure.
Antimicrobial Agents and Chemotherapy 2005, 49, 3062-3065.

2004

Escobar-Páramo P, Grenet K, Le Menac'h A, Rode L, Salgado E, Amorin C, Gouriou S, Picard B, Rahimy MC, Andremont A, Denamur E, Ruimy R
Large-scale population structure of human commensal Escherichia coli isolates.
Applied and Environmental Microbiology 2004, 70, 5698-5700.

2003

Crémieux AC, Muller-Serieys C, Panhard X, Delatour F, Tchimichkian M, Mentre F, Andremont A
Emergence of resistance in normal human aerobic commensal flora during telithromycin and amoxicillin-clavulanic acid treatments.
Antimicrobial Agents and Chemotherapy 2003, 47, 2030-2035.

2002

Lucet JC, Rigaud MP, Mentre F, Kassis N, Deblangy C, Andremont A, Bouvet E
Hand contamination before and after different hand hygiene techniques: a randomized clinical trial.
Journal of Hospital Infection 2002, 50, 276-280.

Denamur E, Bonacorsi S, Giraud A, Duriez P, Hilali F, Amorin C, Bingen E, Andremont A, Picard B, Taddei F, Matic I
High frequency of mutator strains among human uropathogenic Escherichia coli isolates.
Journal of Bacteriology 2002, 184, 605-609.

1999

Lelièvre H, Lina G, Jones ME, Olive C, Forey F, Roussel-Delvallez M, Nicolas-Chanoine MH, Bébéar CM, Jarlier V, Andremont A, Vandenesch F, Etienne J
Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics.
Journal of Clinical Microbiology 1999, 37, 3452-3457.